National trends in radiopharmaceutical use for the diagnosis of cardiac amyloidosis from 2019 to 2024
Year: 2025
Type: article
Source: Journal of Nuclear Cardiology
Institutions: Saint Luke's Hospital, University of Missouri–Kansas City
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
Funders: GE Healthcare, Spectrum
OpenAlex ID: W4414625458
